Karyopharm Therapeutics Inc. buy Robert W. Baird
Start price
13.05.25
/
50%
€0.54
Target price
13.05.26
€37.81
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.05.26. The prediction end date can be changed by Robert_W__Baird at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | -1,66 % | -10,87 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % |
| iShares S&P 500 | -2,30 % | -4,80 % |
Comments by Robert_W__Baird for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Robert W. Baird from $54.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Robert_W__Baird for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
25.03.26
25.03.26
€12.92
25.03.27
25.03.27
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
09.10.25
09.10.25
€18.04
09.10.26
09.10.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
12.08.25
12.08.25
€21.52
12.08.26
12.08.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
03.03.25
03.03.25
€51.55
03.03.26
03.03.26
-
04.03.26
04.03.26
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.72
07.08.24
07.08.24
€4.57
07.08.25
07.08.25
-25.10%
08.08.25
08.08.25